139 related articles for article (PubMed ID: 37164119)
1. Simvastatin ameliorates testosterone-induced prostatic hyperplasia in rats via modulating IGF-1/PI3K/AKT/FOXO signaling.
El-Shafei NH; Zaafan MA; Kandil EA; Sayed RH
Eur J Pharmacol; 2023 Jul; 950():175762. PubMed ID: 37164119
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate mitigates testosterone induced benign prostatic hyperplasia via regulation of Akt/FOXO3a pathway and modulation of apoptosis and proliferation in rats.
Kortam MA; Alawady AS; Hamid Sadik NA; Fathy N
Arch Biochem Biophys; 2022 Jul; 723():109237. PubMed ID: 35430215
[TBL] [Abstract][Full Text] [Related]
3. [Effect of PI3K/AKT inhibitor on benign prostate hyperplasia and its mechanism: an experimental study].
Jin P; Wang YH; Peng YG; Hu S; Lu Q; Yang LY
Zhonghua Nan Ke Xue; 2010 Dec; 16(12):1068-75. PubMed ID: 21348195
[TBL] [Abstract][Full Text] [Related]
4. Targeting HMGB1/PI3K/Akt and NF-κB/Nrf-2 signaling pathways by vildagliptin mitigates testosterone-induced benign prostate hyperplasia in rats.
El-Sahar AE; Bekhit N; Eissa NM; Abdelsalam RM; Essam RM
Life Sci; 2023 Jun; 322():121645. PubMed ID: 37001804
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of
Choi YJ; Fan M; Wedamulla NE; Tang Y; Bae SM; Hwang JY; Kim EK
Food Funct; 2022 Oct; 13(19):10235-10247. PubMed ID: 36124918
[No Abstract] [Full Text] [Related]
6. [
Wang W; Ma F; Wang F; Yang Z; Fan S; Dou G; Gan H; Feng S; Meng Z
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1503-1510. PubMed ID: 36329584
[TBL] [Abstract][Full Text] [Related]
7. Kolaviron modulates angiogenesis, apoptosis and inflammatory signaling in rat model of testosterone propionate-induced benign prostate hyperplasia.
Farombi EO; Ajayi BO; Opata EK; Fafioye AO; Akinade AT
Inflammopharmacology; 2023 Aug; 31(4):2121-2131. PubMed ID: 36881348
[TBL] [Abstract][Full Text] [Related]
8. The extract of Celtis choseniana Nakai alleviates testosterone-induced benign prostatic hyperplasia through inhibiting 5α reductase type 2 and the Akt/NF-κB/AR pathway.
Hong GL; Kim TW; Lee HJ; Kim YJ; Kim KH; Jung JY
Chin J Nat Med; 2022 Jul; 20(7):518-526. PubMed ID: 35907650
[TBL] [Abstract][Full Text] [Related]
9. Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative.
Yang X; Yuan L; Xiong C; Yin C; Ruan J
J Ethnopharmacol; 2014 Nov; 157():105-13. PubMed ID: 25260581
[TBL] [Abstract][Full Text] [Related]
10. Possible therapeutic role of zinc oxide nanoparticles versus vanillic acid in testosterone-induced benign prostatic hyperplasia in adult albino rat: A histological, immunohistochemical and biochemical study.
Abdel Fattah S; Ibrahim MEE; El-Din SS; Emam HS; Algaleel WAA
Life Sci; 2023 Dec; 334():122190. PubMed ID: 37866805
[TBL] [Abstract][Full Text] [Related]
11. The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach.
Mostafa F; Mantawy EM; Azab SS; El-Demerdash E
Eur J Pharmacol; 2019 Dec; 865():172729. PubMed ID: 31605676
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis.
Karunasagara S; Hong GL; Jung DY; Kim KH; Cho K; Jung JY
PLoS One; 2020; 15(8):e0236879. PubMed ID: 32790676
[TBL] [Abstract][Full Text] [Related]
13. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ
Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529
[TBL] [Abstract][Full Text] [Related]
14. Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and PPARs activation effects.
Almukadi H; Eid BG; Shaik RA; Abdel-Naim AB; Esmat A
Biomed Pharmacother; 2021 Nov; 143():112199. PubMed ID: 34649341
[TBL] [Abstract][Full Text] [Related]
15. Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis.
Abo-Youssef AM; Afify H; Azouz AA; Abdel-Rahman HM; Abdel-Naim AB; Allam S
Life Sci; 2020 Nov; 260():118414. PubMed ID: 32926929
[TBL] [Abstract][Full Text] [Related]
16. Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis.
El-Sherbiny M; El-Shafey M; El-Din El-Agawy MS; Mohamed AS; Eisa NH; Elsherbiny NM
Int Immunopharmacol; 2021 Nov; 100():108082. PubMed ID: 34450401
[TBL] [Abstract][Full Text] [Related]
17. Curcuma oil ameliorates benign prostatic hyperplasia through suppression of the nuclear factor-kappa B signaling pathway in rats.
Wang S; Li Y; Li W; Zhang K; Yuan Z; Cai Y; Xu K; Zhou J; Du Z
J Ethnopharmacol; 2021 Oct; 279():113703. PubMed ID: 33340599
[TBL] [Abstract][Full Text] [Related]
18. Modulatory Effect of Silymarin on Apoptosis in Testosterone -Induced Benign Prostatic Hyperplasia in Rats.
El-Ashmawy NE; Khedr EG; El-Bahrawy HA; Helmy NN
Pathol Oncol Res; 2020 Jul; 26(3):1947-1956. PubMed ID: 31902118
[TBL] [Abstract][Full Text] [Related]
19. Caffeic acid phenethyl ester guards against benign prostate hypertrophy in rats: Role of IGF-1R/protein kinase-B (Akt)/β-catenin signaling.
Omar HA; Tolba MF
IUBMB Life; 2018 Jun; 70(6):519-528. PubMed ID: 29603556
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory Effect of Artemisinin on Testosterone Propionate Induced Benign Prostatic Hyperplasia.
Solanki A; Patel S; Solanki N; Shah U
Curr Drug Discov Technol; 2021; 18(4):518-524. PubMed ID: 32532194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
